G-protein-coupled receptor 81 promotes a malignant phenotype in breast cancer through angiogenic factor secretion
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
// Yu Jin Lee 1 , Kyeong Jin Shin 1 , Soo-Ah Park 1 , Kyeong Su Park 1 , Seorim Park 1 , Kyun Heo 2 , Young-Kyo Seo 1 , Dong-Young Noh 3 , Sung Ho Ryu 4 , Pann-Ghill Suh 1 1 School of Life Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan, Republic of Korea 2 New Experimental Therapeutics Branch, Division of Convergence Technology, National Cancer Center, Goyang-si, Republic of Korea 3 Department of Surgery, Seoul National University, College of Medicine, Seoul, Republic of Korea 4 Department of Life Science, Pohang University of Science and Technology (POSTECH), San31, Hyoja Dong, Pohang, Republic of Korea Correspondence to: Pann-Ghill Suh, email: pgsuh@unist.ac.kr Keywords: GPR81, breast cancer, amphiregulin, angiogenesis, Akt Received: April 20, 2016 Accepted: September 02, 2016 Published: September 27, 2016 ABSTRACT G-protein-coupled receptor 81 (GPR81) functions as a receptor for lactate and plays an important role in the regulation of anti-lipolytic effects in adipocytes. However, to data, a role for GPR81 in the tumor microenvironment has not been clearly defined. Here, GPR81 expression in breast cancer patients and several breast cancer cell lines was significantly increased compared with normal mammary tissues and cells. GPR81 knockdown resulted in impaired breast cancer growth and led to apoptosis both in vitro and in vivo . Furthermore, the inhibition of GPR81 signaling suppressed angiogenesis through a phosphoinositide 3-OH kinase (PI3K)/Akt-cAMP response element binding protein (CREB) pathway, which led to decreased production of the pro-angiogenic mediator amphiregulin (AREG). Overall, these findings identify GPR81 as a tumor-promoting receptor in breast cancer progression and suggest a novel mechanism that regulates GPR81-dependent activation of the PI3K/Akt signaling axis in tumor microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · cited 1×
“Angiogenesis, the process of neo-vessels formation, has a key role in breast cancer growth and progression [35].”
BackgroundNormalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“com/oncotarget proangiogenic and antiangiogenic factors in favor of pro-angiogenesis, applies to almost types of solid tumors [36, 37].”
BackgroundComprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Végran, F., Boidot, R., Michiels, C., Sonveaux, P., & Feron, O. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2828 · Cited by 816 · cited 1×
“Although lactate has generally been considered as a by-product of metabolism, recent evidence suggest that lactate functions as an active metabolite and stimulates signaling pathway [32, 33].”
BackgroundG protein-coupled receptors: novel targets for drug discovery in cancer
Lappano, R., & Maggiolini, M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3320 · Cited by 717
Liu, C., Wu, J., Zhu, J., Kuei, C., Yu, J., Shelton, J., Sutton, S. W., Li, X., Yun, S. J., Mirzadegan, T., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806409200 · Cited by 606 · cited 1×
“Endogenous GPR81 expression has been identified in the adipocytes of humans and mice; however, it is also present at low levels in various normal cells such as skeletal muscle and liver [26, 27].”
Background
Cited by
Monocarboxylate transporters in cancer
Payen, V. L., Mina, E., Van Hée, V. F., Porporato, P. E., & Sonveaux, P. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.07.006 · Cited by 644
Brown, T. P., & Ganapathy, V. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107451 · Cited by 481
Lactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity
Wang, J. X., Choi, S. Y. C., Niu, X., Kang, N., Xue, H., Killam, J., & Wang, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218363 · Cited by 460
Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment
Pérez-Tomás, R., & Pérez-Guillén, I. (2020) · Cancers · doi:10.3390/cancers12113244 · Cited by 385
Zhong, X., He, X., Wang, Y., Hu, Z., Huang, H., Zhao, S., Wei, P., & Li, D. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01358-5 · Cited by 329
Metadata
- Authors
- Lee, Y. J., Shin, K. J., Park, S.-A., Park, K. S., Park, S., Heo, K., Seo, Y.-K., Noh, D.-Y., Ryu, S. H., & Suh, P.-G.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-09-27
- Volume
- 7
- Issue
- 43
- Pages
- 70898-70911
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2524915496
- Cited by
- 144
- References
- 8
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: G-protein-coupled receptor 81 promotes a malignant phenotype in breast cancer through angiogenic factor secretion. https://app.cochat.ai/papers/10.18632/oncotarget.12286
- The paper
- Lee, Y. J., Shin, K. J., Park, S.-A., Park, K. S., Park, S., Heo, K., Seo, Y.-K., Noh, D.-Y., Ryu, S. H., & Suh, P.-G. (2016). G-protein-coupled receptor 81 promotes a malignant phenotype in breast cancer through angiogenic factor secretion. Oncotarget. https://doi.org/10.18632/oncotarget.12286
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.